These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alpha radioimmunotherapy using Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220 [TBL] [Abstract][Full Text] [Related]
5. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction. Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373 [TBL] [Abstract][Full Text] [Related]
9. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry. Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201 [TBL] [Abstract][Full Text] [Related]
10. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry. Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708 [TBL] [Abstract][Full Text] [Related]
11. Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent Vaughn BA; Lee SG; Vargas DB; Seo S; Rinne SS; Xu H; Guo HF; Le Roux AB; Gajecki L; Krebs S; Yang G; Ouerfelli O; Zanzonico PB; Fung EK; St Jean S; Carrasco SE; Jungbluth A; Cheung NKV; Larson SM; Veach DR; Cheal SM J Nucl Med; 2024 Oct; 65(10):1611-1618. PubMed ID: 39168519 [TBL] [Abstract][Full Text] [Related]
12. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging. Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309 [TBL] [Abstract][Full Text] [Related]
13. Harnessing Keinänen O; Fung K; Brennan JM; Zia N; Harris M; van Dam E; Biggin C; Hedt A; Stoner J; Donnelly PS; Lewis JS; Zeglis BM Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28316-28327. PubMed ID: 33106429 [TBL] [Abstract][Full Text] [Related]
14. DOTA-tetrazine probes with modified linkers for tumor pretargeting. Läppchen T; Rossin R; van Mourik TR; Gruntz G; Hoeben FJM; Versteegen RM; Janssen HM; Lub J; Robillard MS Nucl Med Biol; 2017 Dec; 55():19-26. PubMed ID: 29028502 [TBL] [Abstract][Full Text] [Related]
15. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody. Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936 [TBL] [Abstract][Full Text] [Related]
16. Inverse electron demand Diels-Alder click chemistry for pretargeted PET imaging and radioimmunotherapy. Sarrett SM; Keinänen O; Dayts EJ; Dewaele-Le Roi G; Rodriguez C; Carnazza KE; Zeglis BM Nat Protoc; 2021 Jul; 16(7):3348-3381. PubMed ID: 34127865 [TBL] [Abstract][Full Text] [Related]
17. α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts. Heskamp S; Hernandez R; Molkenboer-Kuenen JDM; Essler M; Bruchertseifer F; Morgenstern A; Steenbergen EJ; Cai W; Seidl C; McBride WJ; Goldenberg DM; Boerman OC J Nucl Med; 2017 Jun; 58(6):926-933. PubMed ID: 28232604 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging. Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047 [TBL] [Abstract][Full Text] [Related]